| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019883328 |
| P356 | DOI | 10.1007/S11926-002-0069-Y |
| P698 | PubMed publication ID | 12010607 |
| P50 | author | Steven R Goldring | Q114399448 |
| Ellen M Gravallese | Q117258216 | ||
| P2860 | cites work | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells | Q24315251 | ||
| IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis | Q24563235 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 | ||
| T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines | Q24678115 | ||
| Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 | ||
| IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis | Q24796707 | ||
| A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis | Q28255805 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 | ||
| Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. | Q31996316 | ||
| Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis | Q33564710 | ||
| Bone resorption by cells isolated from rheumatoid synovium | Q33584114 | ||
| The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. | Q33823576 | ||
| The role of cytokines in the pathogenesis of rheumatoid arthritis | Q33823954 | ||
| From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins | Q33860728 | ||
| Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group | Q33885648 | ||
| Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis | Q34064293 | ||
| The human osteoclast precursor circulates in the monocyte fraction | Q34392302 | ||
| Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. | Q34469691 | ||
| Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation | Q35747144 | ||
| Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis | Q35764588 | ||
| TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis | Q35788463 | ||
| Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice | Q36791739 | ||
| Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis | Q37380147 | ||
| Factors predicting outcome of rheumatoid arthritis: results of a followup study | Q41072217 | ||
| Cytokines in the pathogenesis of osteoporosis | Q41736045 | ||
| Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin | Q43937881 | ||
| The erosive front: a topographic study of the junction between the pannus and the subchondral plate in the macerated rheumatoid metacarpal head | Q44063757 | ||
| Osteoclast-like cells in murine collagen induced arthritis | Q47957228 | ||
| The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease. | Q50550086 | ||
| Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. | Q50850177 | ||
| Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. | Q52221782 | ||
| IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. | Q53775252 | ||
| Osteoclast-like cells in an in vitro model of bone destruction by rheumatoid synovium. | Q54003767 | ||
| Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. | Q54003771 | ||
| Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover. | Q54129470 | ||
| Generation of osteoclastic function in mouse bone marrow cultures: multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for osteoclastic differentiation. | Q54355784 | ||
| The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: A controlled magnetic resonance imaging study | Q56420842 | ||
| Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis | Q57232104 | ||
| Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis | Q57232110 | ||
| T Cell Activation Induces Human Osteoclast Formation via Receptor Activator of Nuclear Factor κB Ligand-Dependent and -Independent Mechanisms | Q60524745 | ||
| Effect of calcitonin on bone histomorphometry and bone metabolism in rheumatoid arthritis | Q67753616 | ||
| NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis | Q69277665 | ||
| Failure of cells of the mononuclear phagocyte series to resorb bone | Q70515523 | ||
| Histopathology of the rheumatoid lesion. Identification of cell types at sites of cartilage erosion | Q70580984 | ||
| Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three-year randomized, double-blind trial | Q71016803 | ||
| Bone resorption by tartrate-resistant acid phosphatase-positive multinuclear cells isolated from rheumatoid synovium | Q71055741 | ||
| Organ-specific disease provoked by systemic autoimmunity | Q71838378 | ||
| Parathyroid hormone-related peptide in synovial fluid and disease activity of rheumatoid arthritis | Q71843610 | ||
| Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint | Q72824611 | ||
| Activated T lymphocytes support osteoclast formation in vitro | Q73149439 | ||
| Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group | Q73207664 | ||
| Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme | Q73216181 | ||
| Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor | Q73490934 | ||
| Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis | Q73490940 | ||
| Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis | Q73678529 | ||
| Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients | Q73880310 | ||
| Zoledronate (CGP 42'446), a bisphosphonate, protects against metaphyseal intracortical defects in experimental inflammatory arthritis | Q74300801 | ||
| A novel role of IL-15 in the development of osteoclasts: inability to replace its activity with IL-2 | Q74595874 | ||
| Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium | Q77738643 | ||
| P433 | issue | 3 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 226-231 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | Pathogenesis of bone lesions in rheumatoid arthritis | |
| P478 | volume | 4 |
| Q92659462 | "It's my own fault": Accounts and consequences of falling when living with rheumatoid arthritis |
| Q54188388 | Association of toll-like receptor 4 signaling pathway with steroid-induced femoral head osteonecrosis in rats. |
| Q35620364 | Early changes in bone mineral density measured by digital X-ray radiogrammetry predict up to 20 years radiological outcome in rheumatoid arthritis |
| Q36245404 | Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis. |
| Q37140765 | Etanercept Promotes Bone Formation via Suppression of Dickkopf-1 Expression in Rats with Collagen-Induced Arthritis. |
| Q40643961 | Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis |
| Q37524529 | Immune response associated with Toll-like receptor 4 signaling pathway leads to steroid-induced femoral head osteonecrosis |
| Q36618009 | Mechanisms of bone loss in rheumatoid arthritis |
| Q37812618 | Microarchitectural adaptations in aging and osteoarthrotic subchondral bone issues. |
| Q35086184 | Quantifying not only bone loss, but also soft tissue swelling, in a murine inflammatory arthritis model using micro-computed tomography |
| Q28570898 | RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies |
| Q36860987 | Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. |
| Q79808629 | Regulation of bone lysis in inflammatory diseases |
| Q35554105 | T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis |
| Q36536886 | TNFalpha blockade in human diseases: mechanisms and future directions |
| Q34734335 | Tumor necrosis factor-α signaling in macrophages. |
Search more.